Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Reports

Tumor lysis syndrome associated with bortezomib

A post-hoc analysis after signal detection using the US Food and Drug Administration Adverse Event Reporting System

Sanagawa, Akimasaa,,b; Hotta, Yujib; Kondo, Masahiroa; Nishikawa, Ryoheic; Tohkin, Masahiroc; Kimura, Kazunoria,,b,,d

Author Information
doi: 10.1097/CAD.0000000000000862
  • Buy
  • SDC


Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.